McKesson Corp. (MCK): Price and Financial Metrics
GET POWR RATINGS... FREE!
MCK POWR Grades
- Value is the dimension where MCK ranks best; there it ranks ahead of 95.81% of US stocks.
- MCK's strongest trending metric is Growth; it's been moving down over the last 179 days.
- MCK ranks lowest in Momentum; there it ranks in the 38th percentile.
MCK Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for MCK is -201.73 -- better than merely 0.09% of US stocks.
- MCK's price/sales ratio is 0.18; that's higher than the P/S ratio of merely 2.41% of US stocks.
- MCK's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 0.19% of US stocks.
- Stocks that are quantitatively similar to MCK, based on their financial statements, market capitalization, and price volatility, are PBPB, MSI, RAIL, DMS, and AHT.
- MCK's SEC filings can be seen here. And to visit Mckesson Corp's official web site, go to www.mckesson.com.
MCK Valuation Summary
- MCK's EV/EBIT ratio is -7.6; this is 125.94% lower than that of the median Healthcare stock.
- Over the past 243 months, MCK's price/sales ratio has gone down 0.2.
- Over the past 243 months, MCK's price/sales ratio has gone down 0.2.
Below are key valuation metrics over time for MCK.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
MCK | 2021-08-31 | 0.1 | -59.7 | -7.0 | -7.6 |
MCK | 2021-08-30 | 0.1 | -58.8 | -6.9 | -7.5 |
MCK | 2021-08-27 | 0.1 | -58.8 | -6.9 | -7.5 |
MCK | 2021-08-26 | 0.1 | -57.8 | -6.8 | -7.4 |
MCK | 2021-08-25 | 0.1 | -58.6 | -6.9 | -7.4 |
MCK | 2021-08-24 | 0.1 | -58.6 | -6.9 | -7.4 |
MCK Growth Metrics
- The year over year net cashflow from operations growth rate now stands at 3.84%.
- Its year over year price growth rate is now at 31.89%.
- Its 2 year cash and equivalents growth rate is now at 50.26%.

The table below shows MCK's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2021-12-31 | 257,006 | 4,917 | 1,412 |
2021-09-30 | 250,991 | 4,753 | -4,807 |
2021-06-30 | 245,223 | 3,982 | -4,497 |
2021-03-31 | 238,228 | 4,542 | -4,539 |
2020-12-31 | 237,621 | 5,826 | -4,184 |
2020-09-30 | 234,194 | 4,492 | 2,228 |
MCK's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- MCK has a Quality Grade of C, ranking ahead of 60.07% of graded US stocks.
- MCK's asset turnover comes in at 3.903 -- ranking 8th of 105 Wholesale stocks.
- DPZ, SPRS, and ENS are the stocks whose asset turnover ratios are most correlated with MCK.
The table below shows MCK's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-06-30 | 3.903 | 0.051 | -0.395 |
2021-03-31 | 3.872 | 0.051 | -0.391 |
2020-12-31 | 3.922 | 0.051 | -0.378 |
2020-09-30 | 3.881 | 0.052 | 0.202 |
2020-06-30 | 3.870 | 0.052 | 0.079 |
2020-03-31 | 3.807 | 0.052 | 0.071 |
MCK Price Target
For more insight on analysts targets of MCK, see our MCK price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $240.39 | Average Broker Recommendation | 1.47 (Moderate Buy) |
MCK Stock Price Chart Interactive Chart >
MCK Price/Volume Stats
Current price | $334.96 | 52-week high | $339.94 |
Prev. close | $336.42 | 52-week low | $184.43 |
Day low | $330.15 | Volume | 1,089,900 |
Day high | $336.68 | Avg. volume | 1,187,597 |
50-day MA | $318.57 | Dividend yield | 0.56% |
200-day MA | $253.49 | Market Cap | 48.69B |
McKesson Corp. (MCK) Company Bio
McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools. The company delivers a third of all pharmaceuticals used in North America and employs over 78,000 employees. McKesson had revenues of $238.2 billion in its fiscal year ending March 31, 2021. (Source:Wikipedia)
Latest MCK News From Around the Web
Below are the latest news stories about Mckesson Corp that investors may wish to consider to help them evaluate MCK as an investment opportunity.
Completed Settlements Signal Opioid Litigation Is Drawing to a CloseShares of Johnson & Johnson, AmerisourceBergen, McKesson, and Cardinal Health jumped Friday morning. |
Are These Medical Stocks a Great Value Stocks Right Now?Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. |
Chemed (CHE) Q4 Earnings Surpass Estimates, Revenues MissChemed (CHE) reports better-than-expected earnings for the fourth quarter, with a robust performance by the Roto-Rooter arm driving the top line. |
Myriad Genetics (MYGN) Reports Loss in Q4, Gross Margin ImprovesStrength in Myriad Genetics' (MYGN) Molecular Diagnostic segment has drove Q4 sales despite a challenging business environment. |
Teleflex (TFX) Q4 Earnings & Revenues Top Estimates, Margins UpStrong segmental performance in the domestic and international markets is driving Teleflex's (TFX) fourth-quarter top line. |
MCK Price Returns
1-mo | 4.48% |
3-mo | 21.84% |
6-mo | 50.60% |
1-year | 75.56% |
3-year | 175.33% |
5-year | 118.50% |
YTD | 34.99% |
2021 | 44.23% |
2020 | 27.06% |
2019 | 26.72% |
2018 | -28.40% |
2017 | 11.95% |
MCK Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
Continue Researching MCK
Here are a few links from around the web to help you further your research on Mckesson Corp's stock as an investment opportunity:Mckesson Corp (MCK) Stock Price | Nasdaq
Mckesson Corp (MCK) Stock Quote, History and News - Yahoo Finance
Mckesson Corp (MCK) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...